Page last updated: 2024-09-05
sb 216763 and Asthma
sb 216763 has been researched along with Asthma in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bentley, JK; Bitar, KN; Deng, H; Dokshin, GA; Fingar, DC; Goldsmith, AM; Hershenson, MB; Lei, J | 1 |
Other Studies
1 other study(ies) available for sb 216763 and Asthma
| Article | Year |
|---|---|
Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.
Topics: Animals; Asthma; Bronchi; Cytokines; Enzyme Inhibitors; Eukaryotic Initiation Factor-2B; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypertrophy; Indoles; Lithium Chloride; Maleimides; Mice; Muscle Proteins; Muscle, Smooth; Protein Biosynthesis; RNA, Small Interfering; Signal Transduction | 2008 |